We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Antibiotics Facilitate Intestinal C. difficile Colonization

By HospiMedica International staff writers
Posted on 17 Jan 2016
Print article
A new study sheds light on the way antibiotics can promote C. difficile infections by killing beneficial bile-acid altering bacteria in the microbiota.

Researchers at North Carolina State University (NCSU; Raleigh, USA) and the University of Michigan (Ann Arbor, USA) used targeted bile acid metabolomics in order to define the physiologically relevant concentrations of primary and secondary bile acids present in murine small and large intestinal tracts, and how these bile acids impact C. difficile dynamics. To do so, they first identified 26 different primary and secondary bile acids, and defined the concentrations of those acids before treatment.

The mice were then treated with a variety of antibiotics to create distinct microbial and metabolic bile acid environments in order to test how they supported or inhibited spore germination and outgrowth. They found that the primary bile acids in the small intestine allow spores to germinate, regardless of antibiotic treatment. But when the spores reach the large intestine, secondary bile acids, produced mainly by Lachnospiraceae and Ruminococcaceae microbiota community members, successfully stop this germination.

However, when the beneficial bacteria and their secondary bile acids were not present due to antibiotic treatment, C. difficile spores were able to grow quickly. The susceptibility to C. difficile in the large intestine was observed only after specific broad-spectrum antibiotics (cefoperazone, clindamycin, and vancomycin), and was accompanied by a significant loss of the secondary bile acids deoxycholate, lithocholate, ursodeoxycholate, hyodeoxycholate, and ω-muricholate. The study was published in the January 2016 issue of mSphere.

“We know that within a healthy gut environment, the growth of C. diff is inhibited, but we wanted to learn more about the mechanisms behind that inhibitory effect. These findings are a first step in understanding how the gut microbiota regulates bile acids throughout the intestine,” said lead author assistant professor of infectious diseases Casey Theriot, PhD, of NCSU. “Hopefully, they will aid the development of future therapies for C. difficile infection and other metabolically relevant disorders, such as obesity and diabetes.”

C. difficile exists in the environment as a dormant spore. To colonize the gut, the spores need to germinate and turn in active, toxin-producing bacteria. Antibiotics that alter the gastrointestinal microbiota facilitate this germination, allowing infections to develop, resulting in a significant public health problem.

Related Links:

North Carolina State University
University of Michigan


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Enterprise Imaging & Reporting Solution
Syngo Carbon

Print article

Channels

Surgical Techniques

view channel
Image: The device\'s LEDs light up in several colors, allowing surgeons to see which areas they need to operate on (Photo courtesy of UC San Diego)

Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons

During brain surgery, neurosurgeons need to identify and preserve regions responsible for critical functions while removing harmful tissue. Traditionally, neurosurgeons rely on a team of electrophysiologists,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.